CBD Product Safety and Standardization Act of 2023
Impact
By providing a clear set of standards, the bill would create an environment where food products containing cannabidiol can be regulated for safety and labeling, thus protecting consumers. This statutory framework would clarify that only food products that comply with these standards could legally contain CBD. As part of the bill, the Secretary of Health is tasked with issuing regulations that will define permissible limits of CBD content per serving, which is expected to significantly influence industry practices and distribution of these products nationwide.
Summary
House Bill 1628, also known as the CBD Product Safety and Standardization Act of 2023, aims to establish a regulatory framework for food products containing cannabidiol derived from hemp. The bill amends the Federal Food, Drug, and Cosmetic Act to include specific standards and regulations applicable to such foods, which were previously ambiguous regarding their legality and safety. The intent of the bill is to ensure that CBD-containing food products are safe for consumers while facilitating their commerce across state lines.
Contention
Notably, there could be points of contention surrounding the implementation of these regulations, particularly regarding what constitutes acceptable labeling and marketing of CBD-infused foods. Some industry stakeholders may argue that stringent regulations may hinder product innovation and limit market potential. Moreover, varying interpretations of safety and effectiveness concerning CBD could lead to debates among regulators, businesses, and consumer advocacy groups about the appropriate level of oversight required for these products.
Relating to the regulation of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and registrations; imposing fees; creating criminal offenses; authorizing an administrative penalty.
Relating to the regulation of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and registrations; imposing fees; creating criminal offenses; authorizing an administrative penalty.
Prohibit conduct relating to hemp other than cannabidiol products and change provisions of the Nebraska Hemp Farming Act and the Uniform Controlled Substances Act
A bill for an act relating to medical cannabidiol by providing deductions from the individual and corporate income taxes for expenses incurred by medical cannabidiol manufacturers and dispensaries, and including retroactive applicability provisions.
Prohibit conduct relating to hemp other than cannabidiol products and change provisions of the Nebraska Hemp Farming Act and the Uniform Controlled Substances Act
A bill for an act relating to the issuance of medical cannabidiol registration cards and licensure of medical cannabidiol dispensaries. (Formerly HSB 224.) Effective date: 07/01/2026